Published ahead of print on January 26, 2006, doi:10.1164/rccm.200508-1344OC
Am. J. Respir. Crit. Care Med., Volume 173, Number 9, May 2006, 985-990
A more recent version of this article appeared on May 1, 2006
Submitted on August 30, 2005
Accepted on January 26, 2006
Lung Function Decline and Outcomes in an Adult Population
David M Mannino1*, Matthew M Reichert1, and Kourtney J Davis2
1 Division of Pulmonary and Critical Care Medicine, University of Kentucky Medical Center, Lexington, KY, USA,
2 Research and Development, GlaxoSmithKline, Research Triangle Park, NC, USA
* To whom correspondence should be addressed. E-mail: dmannino{at}uky.edu.
Rationale: Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality.
Objectives: To determine risk factors for and outcomes of rapid lung function decline in a cohort of U.S. adults.
Methods: We analyzed data from 15,536 adults aged 44-66 years in the Atherosclerosis Risk in Communities (ARIC) study. We used Cox proportional hazard models to determine the risk of rapid lung function decline at three years on mortality and COPD hospitalizations over the subsequent eight years.
Measurements and Main Results: Of those in the baseline cohort, 13,756 (88.5%) had spirometry at the year 3 visit. The strongest risk factors for not having a follow-up spirometry were being GOLD stage 3 or 4 at baseline (adjusted odds ratio [OR] 2.8, 95% confidence interval [CI] 2.1, 3.8), being of black race (adjusted OR 2.4, 95% CI 2.1, 2.7), and being a current smoker (adjusted OR 1.8, 95% CI 1.5, 2.0). Participants with GOLD stage 3 or 4 were also more likely to be in the most rapidly declining lung function quartile (adjusted OR 3.7, 95% CI 2.7, 5.0). Overall, participants with the most rapidly declining lung function had a modestly increased risk of death (adjusted hazard ratio [HR] 1.4, 95% CI 1.2, 1.7) and time to a COPD-related hospitalization (adjusted HR 1.4, 95% CI 1.2, 1.8).
Conclusion: Rapid lung function decline was independently associated with a modest increased risk of COPD hospitalizations and deaths.
Key words: COPD, lung function, mortality
This article has been cited by other articles:

|
 |

|
 |
 
R P Young, R Hopkins, and T E Eaton
Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence
Postgrad. Med. J.,
August 1, 2009;
85(1006):
414 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kohansal, P. Martinez-Camblor, A. Agusti, A. S. Buist, D. M. Mannino, and J. B. Soriano
The Natural History of Chronic Airflow Obstruction Revisited: An Analysis of the Framingham Offspring Cohort
Am. J. Respir. Crit. Care Med.,
July 1, 2009;
180(1):
3 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Nettleton, J. L. Follis, and M. B. Schabath
Coffee Intake, Smoking, and Pulmonary Function in the Atherosclerosis Risk in Communities Study
Am. J. Epidemiol.,
June 15, 2009;
169(12):
1445 - 1453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Godtfredsen, T. H. Lam, T. T. Hansel, M. E. Leon, N. Gray, C. Dresler, D. M. Burns, E. Prescott, and J. Vestbo
COPD-related morbidity and mortality after smoking cessation: status of the evidence
Eur. Respir. J.,
October 1, 2008;
32(4):
844 - 853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P-O Bridevaux, M W Gerbase, N M Probst-Hensch, C Schindler, J-M Gaspoz, and T Rochat
Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD
Thorax,
September 1, 2008;
63(9):
768 - 774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri
Update in Chronic Obstructive Pulmonary Disease 2006
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1222 - 1232.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Leo, P. Scanagatta, P. Baglio, D. Radice, G. Veronesi, P. Solli, F. Petrella, and L. Spaggiari
The risk of pneumonectomy over the age of 70.: A case-control study
Eur. J. Cardiothorac. Surg.,
May 1, 2007;
31(5):
779 - 782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Quanjer, J. P. Schouten, M. R. Miller, and G. Ruppel
Avoiding Bias in the Annualized Rate of Change of FEV1
Am. J. Respir. Crit. Care Med.,
February 1, 2007;
175(3):
291 - 292.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Mannino, M. M. Reichert, and K. J. Davis
Am. J. Respir. Crit. Care Med.,
February 1, 2007;
175(3):
292 - 292.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. de Marco, S. Accordini, I. Cerveri, A. Corsico, J. M. Anto, N. Kunzli, C. Janson, J. Sunyer, D. Jarvis, S. Chinn, et al.
Incidence of Chronic Obstructive Pulmonary Disease in a Cohort of Young Adults According to the Presence of Chronic Cough and Phlegm
Am. J. Respir. Crit. Care Med.,
January 1, 2007;
175(1):
32 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 American Thoracic Society
|
|
|